Stocks · Health care · Pharmaceutical Preparations

Arcus Biosciences, Inc.

RCUS Clue Score44
United States Fiscal year ends December CIK 0001724521 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Carolyn C. Tang
11 Jun 2026
General Counsel
Exercised, kept
34,090
$2.57
$87.75K
Yasunori Kaneko
5 Jun 2020
Director
Exercised, kept
35,000
$7.99
$279.65K

What was left out

Form 4 filings counted 258
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 61
Sales straight out of an exercise 5
Sales at will 85
Transactions with no price 0
Shares from compensation/vesting 20,866,287
Sales filed before the plan box existed 84
History held since 19 Mar 2018